Endoscopic FHL Transfer for Acute Achilles Tendon Rupture
Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Oct 12, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This evaluation will be performed by examining the following parameters:
1. Patient satisfaction quantified with the Achilles tendon Total Rupture Score (ATRS). This is the primary outcome.
2. Complication rate
3. Ankle and Calf circumference compared to the contralateral healthy limb.
4. Passive and Active range of ankle motion compared to the contralateral healthy limb.
5. Hallux flexion force compared to the contralateral healthy limb.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed Consent Form
- • Acute Achilles Tendon Rupture (\<4 weeks)
- • Underwent operative treatment with Endoscopic Flexor Hallucis Longus transfer
- • More than 24 months postoperative follow-up
- • Patients operated after 2015
- Exclusion Criteria:
- • Inability or Unwillingness to cooperate
- • Medically unfit for examination
- • Age less than 18 or more than 75 years
- • Non-operative Management or any other Surgical Management
- • Neglected Achilles Tendon Rupture (\>4 weeks)
- • Bilateral Achilles Tendon Rupture
- • Patients operated before 1.1.2015 or after 1.1.2023
- • Comorbidities interfering with the secondary outcomes (e.g. Venous insufficiency resulting in lower limb excessive edema interferes with ankle and calf circumference, rheumatoid arthritis and/or previous foot and ankle surgery interferes with active and passive range of motion of the ankle, etc)
About Aristotle University Of Thessaloniki
Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Náousa, Central Macedonia, Greece
Patients applied
Trial Officials
Michail Kotsapas, MD, MSc
Principal Investigator
General Hospital of Naousa, Department of Orthopedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported